146 related articles for article (PubMed ID: 36513453)
1. The visceral adiposity index and lipid accumulation product as predictors of cardiovascular events in normal weight subjects.
Darroudi S; Soflaee SS; Hosseini ZS; Farmad MS; Mirshafiei H; Sheikh Andalibi MS; Eslamiyeh M; Donyadideh G; Aryan R; Ekhteraee Toosi MS; Talkhi N; Esmaily H; Samadi S; Mohammadpour AH; Rad MA; Ferns GA; Ghayour-Mobarhan M; Moohebati M
Clin Nutr ESPEN; 2022 Dec; 52():190-197. PubMed ID: 36513453
[TBL] [Abstract][Full Text] [Related]
2. Association of Visceral Obesity Indices With Incident Diabetic Retinopathy in Patients With Diabetes: Prospective Cohort Study.
Chen J; Li YT; Niu Z; He Z; Xie YJ; Hernandez J; Huang W; Wang HHX;
JMIR Public Health Surveill; 2024 Feb; 10():e48120. PubMed ID: 38319705
[TBL] [Abstract][Full Text] [Related]
3. Higher visceral adiposity index and lipid accumulation product in relation to increased risk of atherosclerotic burden in community-dwelling older adults.
Sun J; Meng X; Huang H; Jing J; Pan Y; Mei L; Jin A; Wang Y; Wei T; Cai X
Exp Gerontol; 2023 Apr; 174():112115. PubMed ID: 36758647
[TBL] [Abstract][Full Text] [Related]
4. Lipid accumulation product and incident cardiovascular events in a normal weight population: Tehran Lipid and Glucose Study.
Hosseinpanah F; Barzin M; Mirbolouk M; Abtahi H; Cheraghi L; Azizi F
Eur J Prev Cardiol; 2016 Jan; 23(2):187-93. PubMed ID: 25381336
[TBL] [Abstract][Full Text] [Related]
5. Lipid accumulation product and visceral adiposity index are effective markers for identifying the metabolically obese normal-weight phenotype.
Du T; Yu X; Zhang J; Sun X
Acta Diabetol; 2015 Oct; 52(5):855-63. PubMed ID: 25690647
[TBL] [Abstract][Full Text] [Related]
6. Association of lipid accumulation product and visceral adiposity index with the risk of hypertension among oil workers in Xinjiang, China.
Muheiyati G; Mei Y; Tao N
PeerJ; 2023; 11():e15273. PubMed ID: 37214102
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of visceral adiposity indices and lipid accumulation products in the identification of adults at high cardiovascular risk.
Milla AMG; Chagas EBF; Miola VFB; Zanuso BO; Guiguer EL; Araújo AC; Tofano RJ; Quesada KR; Laurindo LF; Barbalho SM
Clin Investig Arterioscler; 2023; 35(5):236-242. PubMed ID: 37121826
[TBL] [Abstract][Full Text] [Related]
8. Visceral adiposity index and lipid accumulation product as a predictor of type 2 diabetes mellitus: The Bogor cohort study of non-communicable diseases risk factors.
Nusrianto R; Ayundini G; Kristanti M; Astrella C; Amalina N; Muhadi ; Riyadina W; Tahapary DL; Soewondo P
Diabetes Res Clin Pract; 2019 Sep; 155():107798. PubMed ID: 31330161
[TBL] [Abstract][Full Text] [Related]
9. Lipid accumulation product and visceral adiposity index for incidence of cardiovascular diseases and mortality; results from 13 years follow-up in Isfahan cohort study.
Fakhrolmobasheri M; Abhari AP; Heidarpour M; Paymannejad S; Pourmahdi-Boroujeni M; Saffari AS; Okhovat P; Roohafza H; Sadeghi M; Rabanipour N; Shafie D; Sarrafzadehgan N
Obes Sci Pract; 2024 Feb; 10(1):e713. PubMed ID: 38264005
[TBL] [Abstract][Full Text] [Related]
10. Importance of Measured Body Fat, Visceral Adiposity Index, and Lipid Accumulation Product Index in Predicting Cardiometabolic Risk Factors.
Demirbas N; Kutlu R
Metab Syndr Relat Disord; 2021 Apr; 19(3):174-179. PubMed ID: 33121374
[No Abstract] [Full Text] [Related]
11. Associations of lipid accumulation product, visceral adiposity index, and triglyceride-glucose index with subclinical organ damage in healthy Chinese adults.
Du MF; Zhang X; Hu GL; Mu JJ; Chu C; Liao YY; Chen C; Wang D; Ma Q; Yan Y; Jia H; Wang KK; Sun Y; Niu ZJ; Man ZY; Wang L; Zhang XY; Luo WJ; Gao WH; Li H; Wu GJ; Gao K; Zhang J; Wang Y
Front Endocrinol (Lausanne); 2023; 14():1164592. PubMed ID: 37795361
[TBL] [Abstract][Full Text] [Related]
12. Visceral adiposity index and 10-year cardiovascular disease incidence: The ATTICA study.
Kouli GM; Panagiotakos DB; Kyrou I; Georgousopoulou EN; Chrysohoou C; Tsigos C; Tousoulis D; Pitsavos C
Nutr Metab Cardiovasc Dis; 2017 Oct; 27(10):881-889. PubMed ID: 28851556
[TBL] [Abstract][Full Text] [Related]
13. LIPID ACCUMULATION PRODUCT, VISCERAL ADIPOSITY INDEX, AND CHINESE VISCERAL ADIPOSITY INDEX AS MARKERS OF CARDIOMETABOLIC RISK IN ADULT GROWTH HORMONE DEFICIENCY PATIENTS: A CROSS-SECTIONAL STUDY.
Xie X; Li Q; Zhang L; Ren W
Endocr Pract; 2018 Jan; 24(1):33-39. PubMed ID: 29144802
[TBL] [Abstract][Full Text] [Related]
14. Association between abdominal obesity indices and risk of cardiovascular events in Chinese populations with type 2 diabetes: a prospective cohort study.
Qiao T; Luo T; Pei H; Yimingniyazi B; Aili D; Aimudula A; Zhao H; Zhang H; Dai J; Wang D
Cardiovasc Diabetol; 2022 Nov; 21(1):225. PubMed ID: 36320060
[TBL] [Abstract][Full Text] [Related]
15. Lipid Accumulation Product (LAP) and Visceral Adiposity Index (VAI) as Markers of Insulin Resistance and Metabolic Associated Disturbances in Young Argentine Women with Polycystic Ovary Syndrome.
Abruzzese GA; Cerrrone GE; Gamez JM; Graffigna MN; Belli S; Lioy G; Mormandi E; Otero P; Levalle OA; Motta AB
Horm Metab Res; 2017 Jan; 49(1):23-29. PubMed ID: 27571188
[TBL] [Abstract][Full Text] [Related]
16. Visceral Adiposity Measurements, Metabolic and Inflammatory Profi le in Obese Patients with and Without Type 2 Diabetes Mellitus: A Crosssectional Analysis.
Wanderley Rocha DR; Jorge AR; Braulio VB; Arbex AK; Marcadenti A
Curr Diabetes Rev; 2017; 13(1):11-18. PubMed ID: 26467189
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the novel three lipid indices for predicting five- and ten-year incidence of cardiovascular disease: findings from Kerman coronary artery disease risk factors study (KERCADRS).
Jafari A; Najafipour H; Shadkam M; Aminizadeh S
Lipids Health Dis; 2023 Oct; 22(1):169. PubMed ID: 37798657
[TBL] [Abstract][Full Text] [Related]
18. Are visceral adiposity index and lipid accumulation product reliable indices for metabolic disturbances in patients with type 2 diabetes mellitus?
Kavaric N; Klisic A; Ninic A
J Clin Lab Anal; 2018 Mar; 32(3):. PubMed ID: 28632304
[TBL] [Abstract][Full Text] [Related]
19. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
20. Visceral adiposity indices and cardiometabolic risk markers in patients with hypertension.
Dos Santos Sena B; da Silva Pastich Gonçalves FCL; Maio R; Silva RPP; da Conceição Chaves de Lemos M; de Arruda IKG
Arch Endocrinol Metab; 2023 Mar; 67(2):224-232. PubMed ID: 36468922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
